KRONOS BIO

kronos-bio-logo

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.

#SimilarOrganizations #People #Financial #Event #Website #More

KRONOS BIO

Social Links:

Industry:
Biotechnology Chemical Therapeutics

Founded:
2017-01-01

Address:
San Mateo, California, United States

Country:
United States

Website Url:
http://www.kronosbio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
278 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.


Current Advisors List

jakob-loven_image

Jakob Loven Board of Directors @ Kronos Bio
Board_member

marianne-de-backer_image

Marianne De Backer Member Board of Directors @ Kronos Bio
Board_member
2021-01-01

Current Employees Featured

angela-koehler_image

Angela Koehler
Angela Koehler Scientific Founder @ Kronos Bio
Scientific Founder
2017-11-01

christopher-wilfong_image

Christopher Wilfong
Christopher Wilfong Chief Operating Officer and Co-Founder @ Kronos Bio
Chief Operating Officer and Co-Founder
2017-11-01

norbert-bischofberger_image

Norbert Bischofberger
Norbert Bischofberger President & Chief Executive Officer @ Kronos Bio
President & Chief Executive Officer
2018-08-01

jorge-dimartino_image

Jorge DiMartino
Jorge DiMartino Chief Medical Officer & Executive Vice President, Clinical Development @ Kronos Bio
Chief Medical Officer & Executive Vice President, Clinical Development
2019-12-01

douglas-c-saffran_image

Douglas C. Saffran
Douglas C. Saffran Vice President, Pharmacology @ Kronos Bio
Vice President, Pharmacology
2018-08-01

zung-to_image

Zung To
Zung To Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality @ Kronos Bio
Hematology Franchise Leader, VP Development Operations, Portfolio Management, Biometrics & Quality
2020-05-01

wes-trotter_image

Wes Trotter
Wes Trotter Vice President, Chemistry @ Kronos Bio
Vice President, Chemistry
2020-01-01

charles-lin_image

Charles Lin
Charles Lin Vice President, Biology @ Kronos Bio
Vice President, Biology
2019-12-01

christopher-lee_image

Christopher Lee
Christopher Lee Vice President, Program Management @ Kronos Bio
Vice President, Program Management

yasir-b-al-wakeel_image

Yasir B. Al-Wakeel
Yasir B. Al-Wakeel CFO & Head of Corporate Development @ Kronos Bio
CFO & Head of Corporate Development
2020-01-01

Founder


angela-koehler_image

Angela Koehler

christopher-wilfong_image

Christopher Wilfong

joshua-kazam_image

Joshua Kazam

Stock Details


Company's stock symbol is NASDAQ:KRON

Investors List

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Private Equity Round - Kronos Bio

vida-ventures_image

Vida Ventures

Vida Ventures investment in Private Equity Round - Kronos Bio

commodore-capital_image

Commodore Capital

Commodore Capital investment in Private Equity Round - Kronos Bio

woodline-partners_image

Woodline Partners

Woodline Partners investment in Private Equity Round - Kronos Bio

nextech-invest_image

Nextech Invest

Nextech Invest investment in Private Equity Round - Kronos Bio

invus_image

Invus

Invus investment in Private Equity Round - Kronos Bio

google-ventures_image

GV

GV investment in Private Equity Round - Kronos Bio

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Private Equity Round - Kronos Bio

blackrock_image

BlackRock

BlackRock investment in Private Equity Round - Kronos Bio

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Private Equity Round - Kronos Bio

Official Site Inspections

http://www.kronosbio.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.27 K

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 3.33.130.190
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Kronos Bio"

About - Kronos Bio

Kronos Bio, Inc. 301 Binney Street 2nd Floor East Cambridge, MA 02142 +1 (650) 781-5200See details»

Company - Kronos Bio

About Us We are a clinical-stage biopharmaceutical company discovering and developing therapeutics that target the deregulated transcription that causes cancer and autoimmune diseases. We find meaning in bringing forward …See details»

Kronos Bio - Crunchbase Company Profile & Funding

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that …See details»

Kronos Bio Enters into Agreement to Be Acquired by Concentra ...

4 days ago CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small …See details»

Kronos Bio Implements New Leadership Structure to …

Jan 25, 2024 Company eliminates three executive officer roles and appoints new Executive Leadership teamSAN MATEO, Calif., and CAMBRIDGE, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON ...See details»

Kronos Bio Reports Third Quarter 2024 Financial Results and …

Sep 30, 2024 [email protected] . Contact. Headquarters. Kronos Bio, Inc. 1300 So. El Camino Real Suite 400 San Mateo, CA 94402 +1 (650) 781-5200. Research Facility. Kronos …See details»

Kronos Bio - LinkedIn

Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases.See details»

Kronos Bio, Inc. Company Profile | San Mateo, CA | Competitors ...

Find company research, competitor information, contact details & financial data for Kronos Bio, Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»

Working At Kronos Bio: Company Overview and Culture - Zippia

Www.kronosbio.com. Organization Type. Public. CEO. Norbert W. Bischofberger. Social Media. Kronos Bio is dedicated to the research and development of first-in-class therapies that …See details»

Kronos Bio - Kronos Bio

Our Vision Create a world where no life is cut short by cancer or other serious diseases. Our Science Medicines that reach traditionally hard-to-reach targets. Transcription factors have …See details»

Kronos Bio, Inc. - AnnualReports.com

Kronos Bio is a biopharmaceutical company that is advancing two investigational compounds in clinical trials for patients with cancer. The company is developing the CDK9 inhibitor KB-0742 as a treatment for MYC-amplified solid tumors …See details»

Kronos Bio Company Profile | Management and Employees List

Kronosbio. Primary Industries. Manufacturing Pharmaceuticals. Contact Information. Headquarters. 1300 S El Camino Real Ste 400, San Mateo, California, 94402, United States …See details»

Kronos Bio Strengthens Senior Management Team with New …

Oct 24, 2019 [email protected]. Media Contact: Sheryl Seapy W2O pure +1 213-262-9390 [email protected]. Contact. Headquarters. Kronos Bio, Inc. 1300 So. El …See details»

Kronos Bio - Work in biotech

Kronos Bio is developing therapeutics that target dysregulated transcription that underpins most human diseases. Individual transcription factors, which dictate expression of a subset of …See details»

Kronos Bio - Craft

Oct 29, 2024 Kronos Bio has 1 employees across 3 locations and $6.29 m in annual revenue in FY 2023. See insights on Kronos Bio including office locations, competitors, revenue, …See details»

Deborah Knobelman, Ph.D. - Kronos Bio

Kronos Bio, Inc. 301 Binney Street 2nd Floor East Cambridge, MA 02142 +1 (650) 781-5200See details»

Kronos Bio - Company Profile & Staff Directory - ContactOut

Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline …See details»

Science - Kronos Bio

Our Science Deregulated transcription is a hallmark of cancer and autoimmune diseases. Kronos Bio is focused on developing medicines that target deregulated transcription factor activity. In …See details»

Kronos Bio Enters into Agreement to Be Acquired by

4 days ago CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small …See details»

Kronos Bio Enters into Agreement to Be Acquired by Concentra ...

4 days ago For more information, visit https://www.kronosbio.com. Advisors Goodwin Procter LLP is acting as legal counsel to Kronos Bio and Leerink Partners is acting as sole financial …See details»

linkstock.net © 2022. All rights reserved